ADVANCE INJECTABLES EXCELLENCE
Dead / Abandoned — Abandoned — no statement of use filed (as of 14 Feb 2022)
What this means for you
This application is over — abandoned 14 Feb 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87905941
- Mark type
- Stylized text
- Filed
- 03 May 2018
- Published for opposition
- 14 May 2019
- Abandoned
- 14 Feb 2022
- Attorney of record
- Mark A. Paskar
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical injectable drugs for the treatment and prevention of cancer, cardiovascular disease, infections, pain, arthritis, psoriasis, diabetes, multiple sclerosis, anemia, hepatitis, hemophilia, osteoporosis, asthma, cystic fibrosis, pancreatitis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, systemic lupus erythematous, macular degeneration, migraines, growth hormone deficiency, chronic idiopathic urticaria, infertility, paroxysmal nocturnal hemoglobinuria, pneumonia, respiratory syncytial virus, varicella virus, human papillomavirus, and meningococcal disease
Owner
- Sagent Pharmaceuticals, Inc., Schaumburg, IL, US
- Sagent Pharmaceuticals, Inc., Schaumburg, IL, US
Prosecution history
- 14 Feb 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 14 Feb 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 18 Jun 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Jun 2021 — SOU EXTENSION 4 GRANTED
- 16 Jun 2021 — SOU EXTENSION 4 FILED
- 16 Jun 2021 — SOU TEAS EXTENSION RECEIVED
- 16 Dec 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Dec 2020 — SOU EXTENSION 3 GRANTED
- 14 Dec 2020 — SOU EXTENSION 3 FILED
- 14 Dec 2020 — SOU TEAS EXTENSION RECEIVED
- 18 Jun 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Jun 2020 — SOU EXTENSION 2 GRANTED
- 16 Jun 2020 — SOU EXTENSION 2 FILED
- 16 Jun 2020 — SOU TEAS EXTENSION RECEIVED
- 10 Jan 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED